This company has been acquired
AUGX Stock Overview
Provides remote medical documentation solutions and live clinical support services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Augmedix, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.35 |
| 52 Week High | US$6.25 |
| 52 Week Low | US$0.73 |
| Beta | -0.19 |
| 1 Month Change | 1.73% |
| 3 Month Change | 135.00% |
| 1 Year Change | -53.37% |
| 3 Year Change | -55.24% |
| 5 Year Change | n/a |
| Change since IPO | -53.00% |
Recent News & Updates
Recent updates
Augmedix, Inc. (NASDAQ:AUGX) Stock's 38% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jun 19
Is Augmedix, Inc. (NASDAQ:AUGX) Trading At A 40% Discount?
May 21Augmedix, Inc. (NASDAQ:AUGX) Shares Slammed 29% But Getting In Cheap Might Be Difficult Regardless
Apr 25Augmedix: Secular AI Tailwinds, But Still Unattractive Risk-Reward
Mar 24Augmedix, Inc. (NASDAQ:AUGX) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Nov 09Augmedix reports Q2 results
Aug 08Augmedix: A Splendid Long-Term Investing Opportunity
Jan 21Shareholder Returns
| AUGX | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0.9% | 5.9% | -0.3% |
| 1Y | -53.4% | 5.9% | 20.4% |
Return vs Industry: AUGX underperformed the US Healthcare Services industry which returned 1% over the past year.
Return vs Market: AUGX underperformed the US Market which returned 34.1% over the past year.
Price Volatility
| AUGX volatility | |
|---|---|
| AUGX Average Weekly Movement | 41.8% |
| Healthcare Services Industry Average Movement | 11.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 18.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AUGX's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: AUGX's weekly volatility has increased from 24% to 42% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 1,430 | Manny Krakaris | www.augmedix.com |
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient’s health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones.
Augmedix, Inc. Fundamentals Summary
| AUGX fundamental statistics | |
|---|---|
| Market cap | US$116.16m |
| Earnings (TTM) | -US$23.85m |
| Revenue (TTM) | US$51.58m |
2.3x
P/S Ratio-4.9x
P/E RatioIs AUGX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AUGX income statement (TTM) | |
|---|---|
| Revenue | US$51.58m |
| Cost of Revenue | US$26.71m |
| Gross Profit | US$24.87m |
| Other Expenses | US$48.72m |
| Earnings | -US$23.85m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.48 |
| Gross Margin | 48.22% |
| Net Profit Margin | -46.23% |
| Debt/Equity Ratio | 196.1% |
How did AUGX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/10/03 20:51 |
| End of Day Share Price | 2024/10/03 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Augmedix, Inc. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| William Sutherland | Benchmark Company |
| Yuan Zhi | B. Riley Securities, Inc. |
| Elizabeth Anderson | Evercore ISI |